New-Onset Type 1 and Type 2 Diabetes Among Korean Youths During the COVID-19 Pandemic
Open Access
- 1 February 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 179 (2) , 155-162
Abstract
Importance: Whether COVID-19 contributes to youth-onset diabetes is controversial, and research in Asia is lacking.Objective: To explore the incidence and severity of diabetes among youths during the COVID-19 pandemic in South Korea.Design, Setting, and Participants: This cohort study used claims data for January 1, 2017, through February 28, 2022, from the National Health Insurance Service database in South Korea. The incidence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in patients younger than 20 years during the pandemic was analyzed and compared with that during the prepandemic period. The study included incident cases of T1D identified by at least 2 diagnosis codes with at least 2 insulin prescriptions within 1 year and T2D identified by at least 2 diagnosis codes with at least 2 prescriptions of diabetes medication within 1 year. Analyses were performed between January 29 and September 2, 2024.Exposures: COVID-19 pandemic and SARS-CoV-2 infection.Main Outcomes and Measures: The primary outcome was incidence of T1D and T2D, and secondary outcomes included the rate of diabetic ketoacidosis (DKA) and association of new-onset diabetes with SARS-CoV-2 positivity.Results: The study included 2599 patients with T1D (mean [SD] age, 12.0 [4.8] years; 1235 [47.5%] male) and 11 040 patients with T2D (mean [SD] age, 16.0 [2.8] years; 6861 [62.1%] male). During the pandemic, the incidence rate ratios were 1.19 (95% CI, 1.10-1.29) for T1D and 1.41 (95% CI, 1.36-1.46) for T2D. The incidence rate of DKA at diagnosis increased during the first pandemic year compared with the prepandemic period (T1D, 42.8% [95% CI, 38.5%-47.0%] vs 31.3% [95% CI, 29.0%-33.7%], respectively; T2D, 6.0% [95% CI, 5.0%-7.1%] vs 2.9% [95% CI, 2.5%-3.3%], respectively) but returned to prepandemic levels in the second pandemic year (T1D, 34.5% [95% CI, 30.6%-38.5%]; T2D, 3.2% [95% CI, 2.6%-3.9%]). The hazard ratio for new-onset diabetes associated with SARS-CoV-2 positivity was 0.44 (95% CI, 0.17-1.13) for T1D and 1.08 (95% CI, 0.74-1.57) for T2D.Conclusions and Relevance: These findings suggest that the incidence and severity of T1D and T2D among South Korean youths increased during the COVID-19 pandemic. The cohort analysis does not support SARS-CoV-2 infection itself as being directly associated with incident diabetes.Keywords
This publication has 51 references indexed in Scilit:
- Incidence of Diabetes in Children and Adolescents During the COVID-19 PandemicJAMA Network Open, 2023
- Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based studyDiabetes & Metabolism, 2023
- Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021JAMA Network Open, 2022
- The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 DiabetesThe Journal of Pediatrics, 2022
- SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, GermanyJAMA, 2022
- School Closures During Social Lockdown and Mental Health, Health Behaviors, and Well-being Among Children and Adolescents During the First COVID-19 WaveJAMA Pediatrics, 2022
- Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021Diabetes Research and Clinical Practice, 2022
- Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19JAMA Pediatrics, 2021
- Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in GermanyJAMA, 2020
- Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record dataPharmacoepidemiology and Drug Safety, 2018